Millennium Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-543,632
| Closed | -$37M | – | 7765 |
|
|
2022
Q3 | $37M | Buy |
543,632
+159,673
| +42% | +$8.81M | 0.02% | 864 |
|
|
2022
Q2 | $12.3M | Buy |
383,959
+71,916
| +23% | +$2.11M | 0.01% | 1792 |
|
|
2022
Q1 | $10.8M | Sell |
312,043
-42,547
| -12% | -$1.27M | 0.01% | 2081 |
|
|
2021
Q4 | $10.4M | Buy |
354,590
+276,967
| +357% | +$8.58M | 0.01% | 2110 |
|
|
2021
Q3 | $1.98M | Buy |
+77,623
| New | +$2.28M | ﹤0.01% | 3938 |
|
|
2021
Q2 | – | Sell |
-360,447
| Closed | -$14.1M | – | 7354 |
|
|
2021
Q1 | $14.7M | Buy |
360,447
+349,977
| +3,343% | +$16.1M | 0.01% | 1388 |
|
|
2020
Q4 | $453K | Sell |
10,470
-550,971
| -98% | -$27.2M | ﹤0.01% | 4269 |
|
|
2020
Q3 | $31K | Buy |
561,441
+252,789
| +82% | +$16.1M | 0.04% | 541 |
|
|
2020
Q2 | $19.5M | Buy |
308,652
+301,020
| +3,944% | +$20.6M | 0.03% | 748 |
|
|
2020
Q1 | $390K | Sell |
7,632
-219,068
| -97% | -$14.7M | ﹤0.01% | 3025 |
|
|
2019
Q4 | $18M | Buy |
226,700
+193,878
| +591% | +$11.5M | 0.02% | 923 |
|
|
2019
Q3 | $1.59M | Buy |
32,822
+8,686
| +36% | +$453K | ﹤0.01% | 2591 |
|
|
2019
Q2 | $1.27M | Sell |
24,136
-115,406
| -83% | -$6.63M | ﹤0.01% | 2662 |
|
|
2019
Q1 | $7.39M | Sell |
139,542
-127,799
| -48% | -$6.28M | 0.01% | 1489 |
|
|
2018
Q4 | $11M | Buy |
267,341
+138,413
| +107% | +$5.19M | 0.02% | 1075 |
|
|
2018
Q3 | $4.9M | Sell |
128,928
-235,949
| -65% | -$10.5M | 0.01% | 1809 |
|
|
2018
Q2 | $16.5M | Buy |
364,877
+234,851
| +181% | +$10.7M | 0.02% | 982 |
|
|
2018
Q1 | $6.28M | Sell |
130,026
-349,812
| -73% | -$19.5M | 0.01% | 1656 |
|
|
2017
Q4 | $18.9M | Buy |
479,838
+469,323
| +4,463% | +$17.5M | 0.03% | 935 |
|
|
2017
Q3 | $326K | Sell |
10,515
-45,092
| -81% | -$1.27M | ﹤0.01% | 3029 |
|
|
2017
Q2 | $1.52M | Buy |
55,607
+12,203
| +28% | +$363K | ﹤0.01% | 2233 |
|
|
2017
Q1 | $1.6M | Buy |
+43,404
| New | +$1.09M | ﹤0.01% | 2136 |
|
|
2016
Q3 | – | Sell |
-134,115
| Closed | -$2.23M | – | 3719 |
|
|
2016
Q2 | $2.23M | Buy |
+134,115
| New | +$2.71M | 0.01% | 1728 |
|
|
2015
Q4 | – | Sell |
-72,168
| Closed | -$3.04M | – | 3877 |
|
|
2015
Q3 | $3.04M | Buy |
+72,168
| New | +$3.4M | 0.01% | 1639 |
|
Other funds holding GBT
Millennium Management's GBT Position: Q4 2022 in Review
Millennium Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 543,632 shares — an estimated $37M sold.
Millennium Management first reported a position in GBT in Q3 2015 and held it in 24 quarters. The position peaked at $37M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- Millennium Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- Millennium Management sold 543,632 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $37M.
- Millennium Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 24 quarters.
- Millennium Management's Global Blood Therapeutics, Inc. position peaked at $37M in Q3 2022.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.